Hide metadata

dc.date.accessioned2023-11-15T16:26:09Z
dc.date.available2023-11-15T16:26:09Z
dc.date.created2023-05-26T10:29:46Z
dc.date.issued2023
dc.identifier.citationHenjum, Helge Dahle, Tordis Johnsen Mairani, Andrea Pilskog, Sara Margareta Cecilia Stokkevåg, Camilla Hanquist Boer, Camilla Grindeland Redalen, Kathrine Røe Minn, Heikki Malinen, Eirik Ytre-Hauge, Kristian Smeland . Combined RBE and OER optimization in proton therapy with FLUKA based on EF5-PET. Journal of Applied Clinical Medical Physics. 2023
dc.identifier.urihttp://hdl.handle.net/10852/105848
dc.description.abstractAbstract Introduction Tumor hypoxia is associated with poor treatment outcome. Hypoxic regions are more radioresistant than well‐oxygenated regions, as quantified by the oxygen enhancement ratio (OER). In optimization of proton therapy, including OER in addition to the relative biological effectiveness (RBE) could therefore be used to adapt to patient‐specific radioresistance governed by intrinsic radiosensitivity and hypoxia. Methods A combined RBE and OER weighted dose (ROWD) calculation method was implemented in a FLUKA Monte Carlo (MC) based treatment planning tool. The method is based on the linear quadratic model, with α and β parameters as a function of the OER, and therefore a function of the linear energy transfer (LET) and partial oxygen pressure (pO 2 ). Proton therapy plans for two head and neck cancer (HNC) patients were optimized with pO 2 estimated from [ 18 F]‐EF5 positron emission tomography (PET) images. For the ROWD calculations, an RBE of 1.1 (RBE 1.1,OER ) and two variable RBE models, Rørvik (ROR) and McNamara (MCN), were used, alongside a reference plan without incorporation of OER (RBE 1.1 ). Results For the HNC patients, treatment plans in line with the prescription dose and with acceptable target ROWD could be generated with the established tool. The physical dose was the main factor modulated in the ROWD. The impact of incorporating OER during optimization of HNC patients was demonstrated by the substantial difference found between ROWD and physical dose in the hypoxic tumor region. The largest physical dose differences between the ROWD optimized plans and the reference plan was 12.2 Gy. Conclusion The FLUKA MC based tool was able to optimize proton treatment plans taking the tumor pO 2 distribution from hypoxia PET images into account. Independent of RBE‐model, both elevated LET and physical dose were found in the hypoxic regions, which shows the potential to increase the tumor control compared to a conventional optimization approach.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleCombined RBE and OER optimization in proton therapy with FLUKA based on EF5-PET
dc.title.alternativeENEngelskEnglishCombined RBE and OER optimization in proton therapy with FLUKA based on EF5-PET
dc.typeJournal article
dc.creator.authorHenjum, Helge
dc.creator.authorDahle, Tordis Johnsen
dc.creator.authorMairani, Andrea
dc.creator.authorPilskog, Sara Margareta Cecilia
dc.creator.authorStokkevåg, Camilla Hanquist
dc.creator.authorBoer, Camilla Grindeland
dc.creator.authorRedalen, Kathrine Røe
dc.creator.authorMinn, Heikki
dc.creator.authorMalinen, Eirik
dc.creator.authorYtre-Hauge, Kristian Smeland
cristin.unitcode185,15,4,50
cristin.unitnameBiofysikk og medisinsk fysikk
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin2149488
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Journal of Applied Clinical Medical Physics&rft.volume=&rft.spage=&rft.date=2023
dc.identifier.jtitleJournal of Applied Clinical Medical Physics
dc.identifier.volume24
dc.identifier.issue9
dc.identifier.pagecount0
dc.identifier.doihttps://doi.org/10.1002/acm2.14014
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn1526-9914
dc.type.versionPublishedVersion
cristin.articleide14014


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International